Cobionix secures US $3 Million in strategic funding to advance autonomous medical robotics

Cobionix, a pioneer in autonomous medical robotics, has closed a US $3 million funding round led by TitletownTech, a venture capital firm backed by Microsoft and the Green Bay Packers. Lions Investment and Dr. Paul McBeth, a prominent medical robotics KOL, also participated among others. This funding will support the commercialization of CODI®, Cobionix’s multi-functional robotic platform designed to enhance healthcare delivery through advanced automation and AI.

CODI® is a configurable, medical-collaborative robotics platform capable of performing a wide range of patient-facing tasks, including diagnostic ultrasound procedures. Unlike traditional robotic systems that require significant hardware modifications for different clinical applications, CODI’s® design allows for rapid adaptation to various clinical tasks through simple tool changes and over-the-air software updates.

Cobionix is an OBIO® member, an alumnus of our CAAP® and Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence, and presented at the OBIO® Investment Summit.